Limited access to CVD medicines in low-income and middle-income countries: poverty is at the heart of the matter
Lancet Glob Health
.
2018 Mar;6(3):e234-e235.
doi: 10.1016/S2214-109X(18)30048-2.
Authors
Charles Agyemang
1
,
Bert-Jan van den Born
2
Affiliations
1
Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands. Electronic address: c.o.agyemang@amc.uva.nl.
2
Department of Internal and Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
PMID:
29433655
DOI:
10.1016/S2214-109X(18)30048-2
No abstract available
Publication types
Comment
MeSH terms
Developing Countries
Humans
Income*
Poverty*